Yuanbao (YB) Competitors

Yuanbao has lower revenue, but higher earnings than Skyward Specialty Insurance Group. Yuanbao is trading at a lower price-to-earnings ratio than Skyward Specialty Insurance Group, indicating that it is currently the more affordable of the two stocks.

Skyward Specialty Insurance Group has a beta of 0.34, meaning that its stock price is 66% less volatile than the broader market. Comparatively, Yuanbao has a beta of 0.39, meaning that its stock price is 61% less volatile than the broader market.

94.8% of Skyward Specialty Insurance Group shares are owned by institutional investors. 8.5% of Skyward Specialty Insurance Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Yuanbao has a net margin of 29.67% compared to Skyward Specialty Insurance Group's net margin of 11.36%. Yuanbao's return on equity of 44.37% beat Skyward Specialty Insurance Group's return on equity.

Skyward Specialty Insurance Group presently has a consensus price target of $67.67, indicating a potential upside of 11.92%. Yuanbao has a consensus price target of $21.80, indicating a potential upside of 63.66%. Given Yuanbao's higher probable upside, analysts plainly believe Yuanbao is more favorable than Skyward Specialty Insurance Group.

In the previous week, Skyward Specialty Insurance Group had 8 more articles in the media than Yuanbao. MarketBeat recorded 9 mentions for Skyward Specialty Insurance Group and 1 mentions for Yuanbao. Yuanbao's average media sentiment score of 1.87 beat Skyward Specialty Insurance Group's score of 1.28 indicating that Yuanbao is being referred to more favorably in the news media.

Yuanbao currently has a consensus target price of $21.80, suggesting a potential upside of 63.66%. Slide Insurance has a consensus target price of $23.75, suggesting a potential upside of 17.23%. Given Yuanbao's higher probable upside, analysts clearly believe Yuanbao is more favorable than Slide Insurance.

Slide Insurance has a net margin of 38.86% compared to Yuanbao's net margin of 29.67%. Slide Insurance's return on equity of 48.38% beat Yuanbao's return on equity.

In the previous week, Slide Insurance had 1 more articles in the media than Yuanbao. MarketBeat recorded 2 mentions for Slide Insurance and 1 mentions for Yuanbao. Yuanbao's average media sentiment score of 1.87 beat Slide Insurance's score of 0.72 indicating that Yuanbao is being referred to more favorably in the media.

Slide Insurance has higher revenue and earnings than Yuanbao. Yuanbao is trading at a lower price-to-earnings ratio than Slide Insurance, indicating that it is currently the more affordable of the two stocks.

Yuanbao has a net margin of 29.67% compared to Clover Health Investments' net margin of -2.58%. Yuanbao's return on equity of 44.37% beat Clover Health Investments' return on equity.

In the previous week, Clover Health Investments had 4 more articles in the media than Yuanbao. MarketBeat recorded 5 mentions for Clover Health Investments and 1 mentions for Yuanbao. Yuanbao's average media sentiment score of 1.87 beat Clover Health Investments' score of 0.56 indicating that Yuanbao is being referred to more favorably in the news media.

Yuanbao has lower revenue, but higher earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Yuanbao, indicating that it is currently the more affordable of the two stocks.

19.8% of Clover Health Investments shares are owned by institutional investors. 23.5% of Clover Health Investments shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Clover Health Investments has a beta of 2.41, meaning that its stock price is 141% more volatile than the broader market. Comparatively, Yuanbao has a beta of 0.39, meaning that its stock price is 61% less volatile than the broader market.

Clover Health Investments currently has a consensus target price of $4.25, indicating a potential downside of 1.62%. Yuanbao has a consensus target price of $21.80, indicating a potential upside of 63.66%. Given Yuanbao's higher probable upside, analysts clearly believe Yuanbao is more favorable than Clover Health Investments.

Yuanbao has a net margin of 29.67% compared to Fidelis Insurance's net margin of 15.33%. Yuanbao's return on equity of 44.37% beat Fidelis Insurance's return on equity.

In the previous week, Fidelis Insurance had 1 more articles in the media than Yuanbao. MarketBeat recorded 2 mentions for Fidelis Insurance and 1 mentions for Yuanbao. Yuanbao's average media sentiment score of 1.87 beat Fidelis Insurance's score of 0.82 indicating that Yuanbao is being referred to more favorably in the media.

Fidelis Insurance has higher revenue and earnings than Yuanbao. Yuanbao is trading at a lower price-to-earnings ratio than Fidelis Insurance, indicating that it is currently the more affordable of the two stocks.

82.0% of Fidelis Insurance shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Yuanbao pays an annual dividend of $1.24 per share and has a dividend yield of 9.3%. Fidelis Insurance pays an annual dividend of $0.60 per share and has a dividend yield of 2.3%. Yuanbao pays out 30.0% of its earnings in the form of a dividend. Fidelis Insurance pays out 16.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Yuanbao currently has a consensus target price of $21.80, suggesting a potential upside of 63.66%. Fidelis Insurance has a consensus target price of $27.20, suggesting a potential upside of 6.40%. Given Yuanbao's higher possible upside, equities analysts plainly believe Yuanbao is more favorable than Fidelis Insurance.

Yuanbao has a beta of 0.39, meaning that its stock price is 61% less volatile than the broader market. Comparatively, Fidelis Insurance has a beta of 0.29, meaning that its stock price is 71% less volatile than the broader market.